Fundraising Fox

Novaestiq

Southlake, US · Founded 2021 · Delaware corporation

Founders & leadership

ER
Ethan RigelNamed on SEC filing
HA
Humberto AntunesNamed on SEC filing
MD
Miles David HarrisonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$7.4M disclosed across 2 rounds · 2021

$7.4MraisedApr 2024 · 56 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Miles David HarrisonExecutive Officer, Director
  • Humberto AntunesExecutive Officer, Director
  • Ethan RigelExecutive Officer
Offering amount
$10M
Amount sold
$7.4M
Placement agents
Issuer Direct Sales Only
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$28KraisedOct 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ethan RigelExecutive Officer
  • Humberto AntunesExecutive Officer, Director
  • Miles David HarrisonExecutive Officer, Director
Offering amount
$28K
Amount sold
$28K
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Novaestiq raised?
Novaestiq has disclosed $7.4M raised across 2 rounds.
Where is Novaestiq headquartered?
Novaestiq is headquartered in Southlake, US.